Searched for
BOEHRINGER INGELHEIM PHARMACEUTICALS
Boehringer Ingelheim, Viyash Scientific enter pet healthcare pact in IndiaGerman biopharma giant Boehringer Ingelheim is partnering with Viyash Scientific to bring its pet healthcare products to India. This collab...- Indian pharma cos to launch cheaper diabetes medicine at 90% lower price soonDomestic drug companies in India are preparing to launch affordable generics of the diabetes drug Empagliflozin after the expiry of Boehrin...
- Alembic gets USFDA nod for generic medicationAlembic Pharmaceuticals announced approval from the USFDA to market Dabigatran Etexilate Capsules (110 mg) for deep vein thrombosis prophyl...
- Alembic Pharma gets USFDA nod for Dabigatran Etexilate capsulesAlembic Pharmaceuticals Ltd received final approval from the US health regulator for generic Dabigatran Etexilate capsules 75 mg and 150 mg...
- Torrent Pharmaceuticals partner with Boehringer Ingelheim to co-market diabetes, cardiovascular medicinesBoth companies entered into partnership for the sales and co-marketing of Empagliflozin and its combinations including Cospiaq (Empaglifloz...
- Boehringer Ingelheim obtains interim injunction against four Indian drug cos from selling its diabetes drugBI said the injunctions restrain the domestic pharma companies from infringing the patent of Linagliptin by advertising, launching, making,...
- Alembic Pharma gets tentative USFDA nod for generic version of Dabigatran Etexilate capsulesThe tentatively approved ANDA is therapeutically equivalent to the reference listed drug (RLD) product Pradaxa Capsules, 75 mg, 110 mg, and...
- Boehringer Ingelheim gets interim injunction against Dr. Reddy’s Labs, MSN Labs against copies of anti-diabetes drugIn a statement to ET, BI confirmed it has obtained separate orders granting ad-interim injunction that restrains the two domestic pharmaceu...
- Glenmark gets USFDA nod for generic lung cancer drugThe company's product is the generic version of Boehringer Ingelheim Pharmaceuticals Inc's Ofev capsules.
- Alembic Pharmaceuticals gets USFDA's tentative approval for type 2 diabetes drugThe tentatively approved abbreviated new drug application (ANDA) is therapeutically equivalent to the reference listed drug product Glyxamb...
- Alembic Pharma gets tentative nod from USFDA for type-2 diabetes management drugAlembic Pharma said it is currently in litigation with Boehringer Ingelheim in District Court of Delaware and launch of the product will de...
- Glenmark Pharma gets USFDA nod for antiplatelet drugShares of Glenmark Pharma were trading 0.03 per cent higher at Rs 559.20 apiece on the BSE.
- Glenmark inks licensing pact for generic Tiotropium Bromide dry powder inhaler in Western EuropeThis is the second inhalation product in-licensed by Glenmark for the European market after Fluticasone/Salmeterol dry powder inhaler, the ...
- Sanofi, Boehringer Ingelheim close business swap in IndiaSanofi is excited to embrace the incoming CHC brands and people associated with this business, as this is in line with objective of boostin...
- Alembic Pharma gets USFDA nod for hypertension tabletsUSFDA approves Alembic Pharma's Telmisartan and Amlodipine tablets, generic version of Boehringer Ingelheim Pharmaceuticals Inc's Twynsta t...
- German giant Boehringer Ingelheim battles India's Gennova Biopharma over stroke treatmentGennova recently secured marketing authorisation of tenectaplase for stroke patients in India, the first such use of the drug anywhere in t...
- Sanofi, Boehringer Ingelheim seek CCI nod for $25-billion global asset swap dealThe commission will review if the two companies swapping their businesses will cause any adverse impact on the local competition.
- Eli Lilly aims to be among top 20 pharma companies in India by 2020The company lays maximum emphasis on its diabetes portfolio and would be introducing new products to cater to over 60 million patients in t...
- Boehringer Ingelheim, Eli Lilly launch Linagliptin tabletsBoehringer Ingelheim India and Eli Lilly and Company India (Lilly) today said they have launched Linagliptin tablets used for treating diab...
- Sun Pharma gets USFDA nod for Flomax's generic versionSun Pharmaceutical Industries today said that it has received the US health regulator's nod to market a generic version of Flomax tamsulosi...
Load More
